You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

response inhibition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OCD, Tricholemmoma, Skin-Picking Trial (Computerized cognitive training, Computerized training)

Recruiting
  • Obsessive-Compulsive Disorder
  • +2 more
  • Computerized cognitive training
  • Computerized placebo training
  • Milwaukee, Wisconsin
    UWM Anxiety Disorders Laboratory
Dec 29, 2022

OCD Trial in Riverside (Transcranial Magnetic Stimulation)

Recruiting
  • Obsessive-Compulsive Disorder
  • Transcranial Magnetic Stimulation
  • Riverside, Rhode Island
    Emma Pendleton Bradley Hospital
Jul 7, 2022

Food Response, Food Stop, Food Response-inhibition Trial in Jerusalem (Stop signal food task)

Enrolling by invitation
  • Food Response
  • +2 more
  • Stop signal food task
  • Jerusalem, Israel
    Hebrew university of Jerusalem
Sep 21, 2022

Myocardial Infarction, Inflammation Trial in Richmond (SP16)

Completed
  • Myocardial Infarction
  • Inflammation
  • Richmond, Virginia
    Virginia Commonwealth University
Jan 13, 2022

Schizophrenia, Impulsive Behavior Trial in Nashville (Nicotine Patch, 7 Mg/24 Hr, Placebo patch)

Terminated
Has Results
  • Schizophrenia
  • Impulsive Behavior
  • Nicotine Patch, 7 Mg/24 Hr
  • Placebo patch
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hospital
Apr 27, 2022

Healthy Trial in Vancouver (Cannabis oil with a high ratio of THC to CBD, Cannabis oil with a high ratio of CBD to THC, Placebo)

Not yet recruiting
  • Healthy
  • Cannabis oil with a high ratio of THC to CBD
  • +2 more
  • Vancouver, British Columbia, Canada
    B.R.A.I.N. Lab, Institute of Mental Health, Faculty of Medicine,
May 2, 2022

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

And Immuno-meDIated Adverse Events in Anti-cancer

Not yet recruiting
  • Cancer
    • (no location specified)
    Jun 26, 2023

    OCD, Microbiota Trial in Stockholm (Exposure and response inhibition)

    Completed
    • Obsessive-Compulsive Disorder
    • Microbiota
    • Exposure and response inhibition
    • Stockholm, Huddinge, Sweden
      M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst
    Sep 19, 2022

    Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)

    Recruiting
    • Heart Failure
    • LCZ 696
    • +4 more
    • New Haven, Connecticut
      Yale New Haven Hospital
    Dec 27, 2022

    Obesity, Overweight, Weight Loss Trial in Cluj-Napoca (Hypnosis, Food inhibition training, Control)

    Completed
    • Obesity
    • +2 more
    • Hypnosis
    • +2 more
    • Cluj-Napoca, Cluj, Romania
    • +1 more
    Aug 22, 2022

    Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

    Recruiting
    • Glioblastoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Parkinson Disease Trial in Birmingham (Procedure/Surgery: Response Inhibition and Deep Brain Stimulation in Parkinson's disease)

    Recruiting
    • Parkinson Disease
    • Procedure/Surgery: Response Inhibition and Deep Brain Stimulation in Parkinson's disease
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Apr 21, 2022

    Movement Disorders Trial in Birmingham (Response Inhibition and Deep Brain Stimulation in Parkinson's disease)

    Recruiting
    • Movement Disorders
    • Response Inhibition and Deep Brain Stimulation in Parkinson's disease
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Apr 7, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • (no location specified)
    Aug 4, 2022

    Synovial and Adipose Tissue Composition in Overweight/Obese

    Active, not recruiting
    • Rheumatoid Arthritis
    • Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
    • Rome, Italy
      Division of Rheumatology
    Mar 2, 2023

    Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)

    Recruiting
    • Leukemia, Acute Lymphocytic
    • Durham, North Carolina
      Duke Cancer Center
    Jun 28, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)

    Completed
    • Squamous Cell Carcinoma of the Head and Neck
    • [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
    • Stanford, California
      Stanford Hospital and Clinics
    Dec 1, 2022

    Traumatic Brain Injury Trial (transcranial direct current stimulation, transcranial pulsed current stimulation, Sham-no

    Withdrawn
    • Traumatic Brain Injury
    • transcranial direct current stimulation
    • +2 more
    • (no location specified)
    Dec 13, 2021

    Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jun 16, 2022

    Healthy Trial in Basel (Paroxetine, Lysergic Acid Diethylamide, Placebo)

    Not yet recruiting
    • Healthy
    • Basel, Switzerland
      Clinical Pharmacology & Toxicology, University Hospital Basel
    Dec 14, 2021

    Inhibitory Control Training, Gameifaction Trial in Philadelphia (No-Added-Sugar Diet)

    Completed
    • Inhibitory Control Training
    • Gameifaction
    • No-Added-Sugar Diet
    • Philadelphia, Pennsylvania
      Drexel University
    Dec 2, 2020

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Acalabrutinib (Arm A)
    • Acalabrutinib (Arm B)
    • Bethesda, Maryland
      Research Site
    Jan 3, 2023

    Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma Trial in San Francisco, Buffalo (Vactosertib(TEW-7197)/

    Not yet recruiting
    • Urothelial Carcinoma Recurrent
    • Advanced Urothelial Carcinoma
    • Vactosertib(TEW-7197)/ Durvalumab
    • San Francisco, California
    • +1 more
    Sep 22, 2021

    Esophageal Adenocarcinoma Trial in Cologne, München (Durvalumab 50 MG/ML, Tremelimumab)

    Recruiting
    • Esophageal Adenocarcinoma
    • Cologne, Germany
    • +1 more
    Feb 17, 2022